企業プロフィール
Infinity Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- INFI
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for INFI.
企業概要
事業概要
Infinity Pharmaceuticals was an oncology company focused on immuno-oncology and targeted cancer programs before becoming a legacy biotech ticker. Its story was defined by the difficulty of sustaining momentum in a crowded oncology market.
所在地とセクター分類
Infinity was headquartered in the United States and listed on NASDAQ. It sat in small-cap oncology biotechnology.
ビジネスモデルの特徴
The business depended on clinical data, strategic updates, and capital efficiency while advancing a narrow pipeline. Investors historically watched whether the company could produce differentiated cancer assets.
バイオ業界での位置付け
Infinity is best viewed as a historical oncology biotech name. It belongs to the category of small-cap companies where scientific promise was often not enough without capital and execution.
今後のカタリスト
- Infinity Pharmaceuticals is now a legacy / closeout story, so the catalysts are any residual asset or corporate-resolution update. There is no broad live pipeline left.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。